San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

3M Acquires Ivera Medical Corp. for Undisclosed Price

Ivera Medical Corp., a San Diego-based company that makes products that disinfect and protect devices used to access a patient’s bloodstream, is being purchased by 3M Co. of St. Paul, Minn.

By Brittany Meiling February 26, 2015 2:31 p.m.   Share

R&D Costs Leave Receptos With Q4 Net Loss of $38 Million

Receptos Inc., a biopharmaceutical company developing treatments for immune and metabolic diseases, reported a fourth-quarter net loss of $38 million, up from $15 million in the same quarter the previous year.

Orexigen Therapeutics Shares Rise 50 Percent After Filing Patent

Shares of Orexigen Therapeutics Inc. leapt 50 percent after the San Diego company filed a patent for its recently approved weight loss drug Contrave, claiming it reduced heart disease.

Crisi Medical Systems Acquired by Becton, Dickinson and Co.

San Diego-based Crisi Medical Systems Inc., a medical technology company, has been acquired by global firm Becton, Dickinson and Co. (BD).

Denovo Biopharma Gets Exclusive Drug License from Eli Lilly

Denovo Biopharma LLC has exclusively licensed a previously failed late-stage neuroscience drug from global pharma firm Eli Lilly and Co., according to a recent news release.

Sotera Wireless Acquires Reflectance Medical

Sotera Wireless, the Mira Mesa-based medical device company, said on Feb. 25 that it acquired Reflectance Medical Inc. of Westborough, Mass. for undisclosed terms.

Scripps Health Acquires San Diego OB-GYN Medical Group

San Diego OB-GYN Medical Group in Hillcrest has joined Scripps Clinic Medical Group, according to a recent news release. The agreement creates the 14th Scripps Clinic location in San Diego County.

Isis Receives $15 Million Milestone Payment from GlaxoSmithKline

Isis Pharmaceuticals Inc. announced Monday that it has earned a $15 million milestone payment from GlaxoSmithKline Plc.

Mast Therapeutics Releases Results of Heart Failure Treatment

Mast Therapeutics Inc., a clinical stage biopharma company, has released results from a nonclinical study testing the drug vepoloxamer for the treatment of heart failure.

Otonomy Submits Drug for FDA Approval

Otonomy Inc., a company that makes treatments for the middle and inner ear, has submitted a drug candidate for regulatory approval following encouraging Phase 3 data.

Tease photo

Isis Pharmaceuticals Reports Q4 Results

Isis Pharmaceuticals Inc. reported a significantly improved fourth quarter net income of $31 million, up from a net loss of $24.3 million in the same quarter last year.

Formula Is New CEO, New Home, Old Drug

BIOTECH: Investors See Good Bet in Heart Drug

San Diego’s abundance of intellectual capital and venture investors with deep pockets has lured yet another startup from its snow-steeped home to sunny Southern California.

Meritage Pharma Acquired by Drugmaker Shire for $70 Million

Dublin-based drugmaker Shire Plc has acquired San Diego-based Meritage Pharma for an upfront payment of $70 million, with another $175 million contingent on meeting milestones, according to a recent news release.

Tease photo

Chris Bernard Joins Epic Sciences as Chief Commercial Officer

Epic Sciences Inc., a San Diego-based diagnostics company, announced Wednesday the appointment of Chris Bernard as chief commercial officer.

Tandem Diabetes Care to Raise $60 Million in Underwritten Public Offering

Tandem Diabetes Care Inc., a medical device company and manufacturer of insulin pumps, announced in a statement Tuesday that it intends to raise $60 million in an underwritten public offering.